Effect of an iron-chelator on ascorbate-induced cytotoxicity

Free Radical Biology and Medicine

Volumn 23, Issue 2, 1997, Pages 260-270

  Sakagami, Hiroshi ^a   Satoh, Kazue ^a   Fukuchi, Kunihiko ^b   Gomi, Kunihide ^b   Takeda, Minoru ^a  

^a SHOWA UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Ascorbic acid; Ascorbyl radical; Cytotoxicity; Deferoxamine; ESR; Iron; Redox potential

Indexed keywords

ASCORBIC ACID; CHELATING AGENT; DEFEROXAMINE MESYLATE;

APOPTOSIS; ARTICLE; CELL SIZE; CELL STRAIN HL 60; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DNA DEGRADATION; HUMAN; HUMAN CELL; IRON CHELATION; OXIDATION REDUCTION POTENTIAL; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

APOPTOSIS; ASCORBIC ACID; CULTURE MEDIA; DEFEROXAMINE; FREE RADICALS; HL-60 CELLS; HUMANS; OXIDATION-REDUCTION; SIDEROPHORES; TUMOR CELLS, CULTURED;

EID: 0030922112     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00621-1     Document Type: Article

References (36)

1. Sakagami H., Sakagami T., Takeda M., Iwaki K., Takeda K. Determination of sodium 5,6-benzylidene-L-ascorbate and related compounds by high-performance liquid chromatography. J. Chromatogr. 653:1993;37-43.
2. Sakagami H., Asano K., Fukuchi K., Gomi K., Ota H., Kazama K., Tanuma S., Kochi M. Induction of tumor degeneration by sodium benzylideneascorbate. Anticancer Res. 11:1991;1533-1538.
3. Sakagami H., Sakagami T., Yamamura M., Takahashi H., Shibuya I., Takeda M. Stability of sodium 5,6-benzylidene-L-ascorbate. Anticancer Res. 15:1995;1269-1274.
4. Kuribayashi N., Sakagami H., Sakagami T., Niimi E., Shiokawa D., Ikekita M., Takeda M., Tanuma S. Induction of DNA fragmentation in human myelogenous leukemic cell lines by sodium 5,6-benzylidene-L-ascorbate and its related compounds. Anticancer Res. 14:1994;969-976.
5. Sakagami H., Satoh K., Ohata H., Takahashi H., Yoshida H., Iida M., Kuribayashi N., Sakagami T., Momose K., Takeda M. Relation between ascorbyl radical intensity and apoptosis-inducing activity. Anticancer Res. 16:1996;2635-2644.
6. Sakagami H., Satoh K. The interaction between two antioxidants, sodium ascorbate and gallic acid. Radical intensity and apoptosis induction. Anticancer Res. 16:1996;1231-1234.
7. Satoh K., Sakagami H. Ascorbyl radical scavenging activity of polyphenols. Anticancer Res. 16:1996;2885-2890.
8. Satoh K., Sakagami H., Nakamura K. Enhancement of radical intensity and cytotoxic activity of ascorbate by PSK and lignins. Anticancer Res. 16:1996;2981-2986.
9. Satoh K., Sakagami H., Nakamura K. Enhancement of radical intensity and cytotoxic activity of ascorbate by hyperthermia. Anticancer Res. 16:1996;2987-2992.
10. Huebers E., Rasey J.S., Huebers H.A., Nelson N.J. Cell growth in transferrin-free bovine serum. Blood abstr. 68:(Suppl):1986;143.
11. Roginsky V.A., Stegmann H.B. Ascorbyl radical as natural indicator of oxidative stress: Quntitative regularities. Free Radic. Biol. Med. 17:1994;93-103.
12. Halliwell B., Gutteridge J.M.C. Role of free radicals and catalytic metal ions in human disease. An overview. Method Enzymol. 186:1990;1-85.
13. Reichard P., Ehrenbergn A. Ribonucleotide reductase - A radical enzyme. Science. 221:1983;514-519.
14. Dezza L., Cazzola M., Danova M., Carlo-Stella C., Bergamaschi G., Brugnatelli S., Invernizzi R., Mazzini G., Riccardi A., Ascari E. Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: In vitro and in vivo studies. Leukemia. 3:1989;104-107.
15. Fukuchi K., Tomoyasu S., Tsuruoka N., Gomi K. Iron deprivation-induced apoptosis in HL-60 cells. FEBS Letters. 350:1994;139-142.
16. Collins S.J., Gallo R.C., Gallagher R.E. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature. 270:1977;347-349.
17. Stein G.H. An anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J. Cell. Physiol. 99:1979;43-54.
18. Fujinaga S., Sakagami H., Kuribayashi N., Takahashi H., Amano Y., Sakagami T., Takeda M. Possible role of hydrogen peroxide in apoptosis induction by ascorbic acid in human myelogenous leukemic cell lines. Showa Univ. J. Med. Sci. 6:1994;135-144.
19. Sakagami H., Kuribayashi N., Iida M., Hagiwara T., Takahashi H., Yoshida H., Shiota F., Ohata H., Momose K., Takeda M. The requirement for and mobilization of calcium during induction by sodium ascorbate and by hydrogen peroxide of cell death. Life Sciences. 58:1996;1131-1138.
20. Sakagami H., Satoh K., Sugaya K., Iida M., Hirota N., Matsumoto K., Kimura S., Gomi K., Taguchi S., Kato S., Takeda M. Effect of the type of serum in the medium on sodium ascorbate-induced cytotoxicity. Anticancer Res. 16:1996;1937-1942.
21. Tanuma S., Shiokawa D., Tanimoto Y., Ikekita M., Sakagami H., Takeda M., Fukuda S., Kochi M. Benzylideneascorbate induces apoptosis in L929 tumor cells. Biochem. Biophys. Res. Commun. 194:1993;29-35.
22. Aiuchi T., Matsunaga M., Syo M., Nakaya K. The relation between respiratory inhibition and uptake of 1-methyl-isoquinoline (MIQ+) in mitochondria. Neurochem. Int. 28:1996;319-323.
23. Ichimori K., Ishida H., Fukahori M., Nakazawa H., Murakami E. Practical nitric oxide measurement employing a nitric oxide-selective electrode. Rev. Sci. Instrum. 65:1994;2714-2718.
24. Yanagisawa-Shiota F., Sakagami H., Kuribayashi N., Iida M., Sakagami T., Takeda M. Endonuclease activity and induction of DNA fragmentation in human myelogenous leukemic cell lines. Anticancer Res. 15:1995;259-266.
25. Tanuma S., Shiokawa D. Multiple forms of nuclear deoxyribonuclease in rat thymocytes. Biochem. Biophys. Res. Commun. 203:1994;789-797.
26. Nikonova L. S., Beletsky I. P., Umansky S. R. Properties of some nuclear nucleases of rat thymocytes and their changes in radiation-induced apoptosis. Eur. J. Biochem. 215:1993;893-901.
27. Gaido M.L., Cidlowski J.A. Identification, purification, and characterization of a calcium-dependent endonuclease (NUC18) from apoptotic rat thymocytes. J. Biol. Chem. 266:1991;18580-18585.
28. 2+-dependent endonuclease from human spleen: Purification, properties, and role in apoptosis. Biochemistry. 32:1993;9129-9136.
29. Darley-Usmar V. M., Hersey A., Garland L. G. A method for the comparative assessment of antioxidants as peroxyl radical scavenger. Biochem Pharmacol. 38:1989;1465-1469.
30. Brodie C., Siriwardana G., Lucas J., Schleicher R., Terada N., Szepesi A., Gelfand E., Seligman P. Neuroblastoma sensitivity to growth inhibition by deferrioxamine: Evidence for a block in G1 phase of the cell cycle. Cancer Res. 53:1993;3968-3975.
31. Bomford A., Isaac J., Roberts S., Edwards A., Young S., Williams R. The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells. Biochem. J. 236:1986;243-249.
32. Khan M. M. T., Martell A. E. Metal ion and metal chelate catalyzed oxidation of ascorbic acid by molecular oxygen. I. Cupric and ferric ion catalyzed oxidation. J. Am. Chem. Soc. 89:1967;4176-4185.
33. Fujita Y., Komagoe K., Uehara I., Morimoto Y., Hara R. Studies on inhibition mechanism of autoxidation by tannins and flavonoids. IV. Acceleration mechanism of methyl linoleate peroxidation induced by the presence of tannin and Cu(II) ion. (In Japanese) YAKUGAKU ZASSHI. 108:1988;625-634.
34. Buettner G. R. In the absence of catalytic metals ascorbate dose not autoxidize at pH 7: Ascorbate as a test for catalytic metals. J. Biochem. Biophys. Method. 16:1988;27-40.
35. Sakagami, H.; Satoh, K. Prooxidant action of two antioxidants: Ascorbic acid and gallic acid. Anticancer Res. in press ; 1997.
36. Sakagami H., Sakagami T., Yoshida H., Omata T., Shiota F., Takahashi H., Kawazoe Y., Takeda M. Hypochlorite scavenging activity of polyphenols. Anticancer Res. 15:1995;917-922.